Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | March 29, 2018 | April 02, 2018 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Director | April 01, 2013 | April 02, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GILEAD SCIENCES, INC.
Report date March 29, 2018 · Filed April 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 27,375.7941 |
Reported balance
After 2018-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-29 · Grant · Acquired 205.4266 · Balance 27,375.7941 F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.
F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.
F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
WELLS FARGO & COMPANY/MN
Report date April 01, 2013 · Filed April 02, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 61,962.9483 |
Reported balance
After 2013-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2013-04-01 · Grant · Acquired 1,651.7736 · Balance 61,962.9483 F2: Conversion price is 1-for-1 F3: Deferred compensation shares payable in installments depending upon director's election. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 1,122.938 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,122.938 F1: Includes 7.866 shares acquired through Wells Fargo & Company's dividend reinvestment plan on 3/1/2013. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | IndirectThrough Family Trust | 1,000 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 7.866 shares acquired through Wells Fargo & Company's dividend reinvestment plan on 3/1/2013.
F2: Conversion price is 1-for-1
F3: Deferred compensation shares payable in installments depending upon director's election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2010 Filed Apr 2, 2010 21:44 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 1,293.3805 | $31.12 | $40,250.00 |
DisclosureSEC source: 0001127602-10-010343 · form4.xml · derivative · entry 3 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,406.7584 Underlying: Common Stock, $1 2/3 Par Value · 1,293.3805 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1 F2 · derivative.exercise_date: Deferred compensation shares payable in installments depending upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments depending upon director's election. Read SEC document |
| January 04, 2010 Filed Jan 5, 2010 17:53 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 1,565.3946 | $26.99 | $42,250.00 |
DisclosureSEC source: 0001127602-10-000375 · form4.xml · derivative · entry 3 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,058.4064 Underlying: Common Stock, $1 2/3 Par Value · 1,565.3946 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1 F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership Read SEC document |
| October 01, 2009 Filed Oct 2, 2009 15:04 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 1,499.2903 | $28.18 | $42,250.00 |
DisclosureSEC source: 0001127602-09-019936 · form4.xml · derivative · entry 3 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,442.2944 Underlying: Common Stock, $1 2/3 Par Value · 1,499.2903 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1 F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 23:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Shares · Derivative | 1,729.66 | $46.83 | $80,999.98 |
DisclosureSEC source: 0001179110-09-010711 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,729.66 Underlying: Common Stock · 1,729.66 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| July 01, 2009 Filed Jul 1, 2009 20:32 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 2,071.3108 | $24.26 | $50,250.00 |
DisclosureSEC source: 0001193833-09-000111 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,894.1411 Underlying: Common Stock, $1 2/3 par value · 2,071.3108 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership . F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership . Read SEC document |
| May 06, 2009 Filed May 8, 2009 22:57 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-09-007480 · edgar.xml · derivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,406 Underlying: Common Stock · 3,406 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 6, 2010, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 6, 2010, at the end of the first year of service. Read SEC document |
| May 06, 2009 Filed May 8, 2009 22:57 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 9,534 | $0.00 Strike: $44.03 | $0.00 |
DisclosureSEC source: 0001179110-09-007480 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,534 Underlying: Common Stock · 9,534 shares Expires 2019-05-06 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 6, 2010. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 23:20 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantDirector Stock Purchase Option · Derivative | 12,330 | $0.00 Strike: $19.48 | $0.00 |
DisclosureSEC source: 0001193833-09-000094 · edgar.xml · derivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,330 Underlying: Common Stock, $1 2/3 par value · 12,330 shares Expires 2019-04-28 Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 23:20 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Unit · Derivative | 3,594 | $19.48 | $70,011.12 |
DisclosureSEC source: 0001193833-09-000094 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,774.2534 Underlying: Common Stock, $1 2/3 par value · 3,594 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in ten annual installments beginning July 1 following cessation of board membership and continuing annually on March 1. F2 · derivative.expiration_date: Payable in ten annual installments beginning July 1 following cessation of board membership and continuing annually on March 1. Read SEC document |
| April 01, 2009 Filed Apr 2, 2009 16:52 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,388.3427 | $14.24 | $48,250.00 |
DisclosureSEC source: 0001193833-09-000069 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,180.2534 Underlying: Common Stock, $1 2/3 par value · 3,388.3427 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership . F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership . Read SEC document |
| January 01, 2009 Filed Jan 1, 2009 01:56 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 1,382.2931 | $29.48 | $40,750.00 |
DisclosureSEC source: 0001193833-08-000144 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,305.6366 Underlying: Common Stock, $1 2/3 par value · 1,382.2931 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership . F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership . Read SEC document |
| October 01, 2008 Filed Oct 1, 2008 17:11 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 979.2166 | $37.53 | $36,750.00 |
DisclosureSEC source: 0001193833-08-000114 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,758.9084 Underlying: Common Stock, $1 2/3 par value · 979.2166 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership . F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership . Read SEC document |
| October 01, 2008 Filed Jan 1, 2009 01:31 UTC Amendment | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 979.2166 | $37.53 | $36,750.00 |
DisclosureSEC source: 0001193833-08-000136 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,738.125 Underlying: Common Stock, $1 2/3 par value · 979.2166 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership . F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership . Read SEC document |
| July 01, 2008 Filed Jul 3, 2008 23:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Shares · Derivative | 661 | $0.00 Strike: $52.95 | $0.00 |
DisclosureSEC source: 0001179110-08-013382 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661 Underlying: Common Stock · 661 shares Expires not disclosed F1 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F1 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| July 01, 2008 Filed Jul 1, 2008 15:27 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 1,378.9474 | $23.75 | $32,750.00 |
DisclosureSEC source: 0001193833-08-000091 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,594.9741 Underlying: Common Stock, $1 2/3 par value · 1,378.9474 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership . F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership . Read SEC document |
| May 08, 2008 Filed May 9, 2008 23:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $53.23 | $0.00 |
DisclosureSEC source: 0001179110-08-009319 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2018-05-08 F1 · derivative.exercise_date: Options vest quarterly over a period of one year from date of grant. Read SEC document |
| April 29, 2008 Filed Apr 30, 2008 21:41 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantDirector Stock Purchase Option · Derivative | 10,490 | $0.00 Strike: $29.88 | $0.00 |
DisclosureSEC source: 0001193833-08-000072 · edgar.xml · derivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,490 Underlying: Common Stock, $1 2/3 par value · 10,490 shares Expires 2018-04-29 Read SEC document |
| April 29, 2008 Filed Apr 30, 2008 21:41 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Unit · Derivative | 2,343 | $29.88 | $70,008.84 |
DisclosureSEC source: 0001193833-08-000072 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,069.0766 Underlying: Common Stock, $1 2/3 par value · 2,343 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership and continuing annually on March 1. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership and continuing annually on March 1. Read SEC document |
| April 01, 2008 Filed Apr 1, 2008 21:19 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 987.9725 | $29.10 | $28,750.00 |
DisclosureSEC source: 0001193833-08-000046 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,726.0766 Underlying: Common Stock, $1 2/3 par value · 987.9725 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 12,000 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · derivative · entry 32 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2015-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested 100% at time of grant, January 26, 2005 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 36,000 | $0.00 Strike: $15.70 | $0.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · derivative · entry 31 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2014-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vested 100% at time of grant, May 25, 2004 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 600 | $43.93 | $26,358.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 30 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.92 | $4,392.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 29 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.91 | $4,391.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 28 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,600 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,293 | $43.89 | $56,749.77 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 27 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,700 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 407 | $43.88 | $17,859.16 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 26 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,993 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 4,548 | $43.88 | $199,543.50 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 25 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,000 | $43.87 | $87,740.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 24 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,948 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.87 | $4,386.75 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 23 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,948 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,800 | $43.86 | $122,808.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 22 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,048 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.85 | $4,385.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 21 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,848 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,000 | $43.82 | $43,820.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 20 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,948 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.79 | $4,379.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 19 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,948 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 400 | $43.77 | $17,508.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 18 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,048 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.69 | $4,369.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 17 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,448 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 13 | $43.68 | $567.84 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 16 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,548 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 87 | $43.67 | $3,799.29 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 15 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,561 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 14,200 | $43.65 | $619,830.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 14 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,648 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 500 | $43.65 | $21,822.50 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 13 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,848 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 800 | $43.62 | $34,896.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 12 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,348 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 600 | $43.61 | $26,166.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 11 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,148 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,700 | $43.60 | $74,120.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 10 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,748 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,300 | $43.60 | $56,673.50 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 9 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,448 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,300 | $43.59 | $56,667.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 8 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,748 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 500 | $43.58 | $21,790.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 7 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,048 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $43.56 | $8,712.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 6 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,548 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.54 | $4,354.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 5 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,748 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $43.52 | $4,352.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 4 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,848 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 7,052 | $43.50 | $306,762.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 3 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,948 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 12,000 | $16.01 | $192,120.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.